health
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Current use of oral menopausal hormone therapy was associated with an increased rate of venous thromboembolism (VTE) in a nationwide Danish study published in The BMJ, while transdermal therapy was not. Risks of ischemic stroke and myocardial infarct... [5356 chars]
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times
Smartphone retinal imaging could expand global eye care screening
News-Medical
Why does endometriosis only cause major pain for some?
Futurity
Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18
Can your eyes reveal hidden kidney and heart disease? The rise of AI-powered oculomics
theweek.in